Literature DB >> 15364993

Isoenzymatic analysis of 712 strains of Leishmania infantum in the south of France and relationship of enzymatic polymorphism to clinical and epidemiological features.

Francine Pratlong1, Jean-Antoine Rioux, Pierre Marty, Françoise Faraut-Gambarelli, Jacques Dereure, Geneviève Lanotte, Jean-Pierre Dedet.   

Abstract

In the south of France, leishmaniasis due to Leishmania infantum occurs in the following five foci of endemicity (from west to east): Pyrénées-Orientales, Cévennes, Provence, Côte d'Azur, and Corsica. Between 1981 and 2002, 712 Leishmania strains obtained from humans, dogs, cats, and sand flies were studied by isoenzyme analysis. In total, seven zymodemes were identified: MON-1, MON-11, MON-24, MON-29, MON-33, MON-34, and MON-108. The Pyrénées-Orientales focus is characterized by a predominance of human cutaneous leishmaniasis and a high enzymatic polymorphism (five zymodemes). In the other foci, where human visceral leishmaniasis is predominant, only two zymodemes are present. L. infantum MON-1 is the parasite most frequently found, in patients both with and without concomitant human immunodeficiency virus infection. MON-1 is the only zymodeme present in dogs, which act as the reservoir host in all of the foci. In Cévennes, where the complete life cycle of zymodeme MON-1 has been identified, Phlebotomus perniciosus and Phlebotomus ariasi are vectors. The enzymatic polymorphism is compared to that of neighboring countries (Spain and Italy). In Pyrénées-Orientales, small variant zymodemes with electromorphs of heterozygote-like and homozygotic patterns can be explained by different genetic hypotheses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364993      PMCID: PMC516332          DOI: 10.1128/JCM.42.9.4077-4082.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  [Cell fusion in Leishmania (Kinetoplastida, Trypanosomatidae)].

Authors:  G Lanotte; J A Rioux
Journal:  C R Acad Sci III       Date:  1990

2.  [Leishmania tropica in Morocco. IV--Intrafocal enzyme diversity].

Authors:  F Pratlong; J A Rioux; J Dereure; J Mahjour; M Gallego; E Guilvard; G Lanotte; J Perieres; A Martini; A Saddiki
Journal:  Ann Parasitol Hum Comp       Date:  1991

3.  Leishmania infantum and L. major in Algeria.

Authors:  Z Harrat; F Pratlong; S Belazzoug; J Dereure; M Deniau; J A Rioux; M Belkaid; J P Dedet
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Nov-Dec       Impact factor: 2.184

4.  Leishmaniasis in Sardinia. IV. Epidemiological appraisal of cutaneous leishmaniasis and biochemical characterization of isolates.

Authors:  S Bettini; M Gramiccia; L Gradoni; P Biggio; R Loi; F Cottoni; M Pau; M C Atzeni
Journal:  J Trop Med Hyg       Date:  1990-08

5.  The use of isoelectric focusing on polyacrylamide gel for the enzymatic analysis of 'Old World' Leishmania species.

Authors:  R Piarroux; V Trouvé; F Pratlong; A Martini; M Lambert; J A Rioux
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

6.  Leishmania tropica and Leishmania infantum responsible for cutaneous leishmaniasis in Greece: sixteen autochthonous cases.

Authors:  C Frank; M Hadziandoniou; F Pratlong; A Garifallou; J A Rioux
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Mar-Apr       Impact factor: 2.184

7.  [Leishmania infantum variant MON-24 isolated from a cutaneous lesion acquired in the suburban area of Nice (France)].

Authors:  P Marty; F Pratlong; B Marcelet; A Adda; Y Le Fichoux
Journal:  Parasite       Date:  1994-06       Impact factor: 3.000

8.  Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex.

Authors:  F Pratlong; J P Dedet; P Marty; M Portús; M Deniau; J Dereure; P Abranches; J Reynes; A Martini; M Lefebvre
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

9.  HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients.

Authors:  M Gramiccia; L Gradoni; M Troiani
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Mar-Apr       Impact factor: 2.184

10.  Heterogeneity among zymodemes of Leishmania infantum from HIV-positive patients with visceral leishmaniasis in south Italy.

Authors:  M Gramiccia; L Gradoni; M Troiani
Journal:  FEMS Microbiol Lett       Date:  1995-04-15       Impact factor: 2.742

View more
  26 in total

1.  Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia.

Authors:  Tesfaye Gelanew; Zewdu Hurissa; Ermias Diro; Aysheshm Kassahun; Katrin Kuhls; Gabriele Schönian; Asrat Hailu
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Screening of antileishmanial activity from marine sponge extracts collected off the Tunisian coast.

Authors:  Amel Ben Kahla-Nakbi; Najoua Haouas; Ali El Ouaer; Hamadi Guerbej; Karim Ben Mustapha; Hamouda Babba
Journal:  Parasitol Res       Date:  2010-04-01       Impact factor: 2.289

3.  Global genome diversity of the Leishmania donovani complex.

Authors:  Susanne U Franssen; Caroline Durrant; Olivia Stark; Bettina Moser; Tim Downing; Hideo Imamura; Jean-Claude Dujardin; Mandy J Sanders; Isabel Mauricio; Michael A Miles; Lionel F Schnur; Charles L Jaffe; Abdelmajeed Nasereddin; Henk Schallig; Matthew Yeo; Tapan Bhattacharyya; Mohammad Z Alam; Matthew Berriman; Thierry Wirth; Gabriele Schönian; James A Cotton
Journal:  Elife       Date:  2020-03-25       Impact factor: 8.140

4.  Geographical distribution and molecular characterization for cutaneous leishmaniasis species by sequencing and phylogenetic analyses of kDNA and ITS1 loci markers in south-eastern Iran.

Authors:  Maryam Ramezany; Iraj Sharifi; Zahra Babaei; Pooya Ghasemi Nejad Almani; Amireh Heshmatkhah; Alireza Keyhani; Mohammad Reza Aflatoonian; Mohammad Ali Mohammadi; Fatemeh Sharifi; Mehdi Bamorovat
Journal:  Pathog Glob Health       Date:  2018-03-14       Impact factor: 2.894

5.  Transmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.

Authors:  Kayoko Waki; Sujoy Dutta; Debalina Ray; Bala Krishna Kolli; Leyla Akman; Shin-Ichiro Kawazu; Chung-Ping Lin; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2006-12-01

6.  Multiple genetic divergences and population expansions of a Mediterranean sandfly, Phlebotomus ariasi, in Europe during the Pleistocene glacial cycles.

Authors:  S S Mahamdallie; B Pesson; P D Ready
Journal:  Heredity (Edinb)       Date:  2010-08-25       Impact factor: 3.821

7.  Multilocus microsatellite typing as a new tool for discrimination of Leishmania infantum MON-1 strains.

Authors:  Sebastian Ochsenreither; Katrin Kuhls; Matthias Schaar; Wolfgang Presber; Gabriele Schönian
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  The use of fluorescent fragment length analysis (PCR-FFL) in the direct diagnosis and identification of cutaneous Leishmania species.

Authors:  Míriam Tomás-Pérez; Roser Fisa; Cristina Riera
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

9.  Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.

Authors:  Yasuyuki Goto; Randall F Howard; Ajay Bhatia; Joelma Trigo; Maria Nakatani; Eduardo M Netto; Steven G Reed
Journal:  Vet Parasitol       Date:  2008-11-05       Impact factor: 2.738

10.  The Montpellier Leishmania Collection, from a Laboratory Collection to a Biological Resource Center: A 39-Year-Long Story.

Authors:  Francine Pratlong; Yves Balard; Patrick Lami; Loïc Talignani; Christophe Ravel; Jacques Dereure; Michèle Lefebvre; Ghislaine Serres; Patrick Bastien; Jean-Pierre Dedet
Journal:  Biopreserv Biobank       Date:  2016-07-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.